For instance, high-risk MYCN-amplified aggressive cancer cells express high levels of NEAT1_1 relative to NEAT1_2, while non-aggressive cancer cells with a more differentiated phenotype express relatively high levels of NEAT1_2. This evidence concerns the gene MYCN and cancer.